Dietary postbiotics supplementation improves growth, survival rate, antioxidant capacity, non-specific immunity and gut health of juvenile oriental river prawn (Macrobrachium nipponense)

Abstract

Antibiotics use in aquaculture cause multiple adverse effects on aquatic animal health. Accordingly, studies on alternative approaches to antibiotics in aquaculture are urgently required. This study investigated the effects of dietary postbiotics as an alternative to florfenicol antibiotic on growth performance, survival rate, antioxidant capacity, non-specific immunity, and gut health of juvenile oriental river prawn (Macrobrachium nipponense). Seven isonitrogenous and isocaloric experimental diets were formulated containing 0% (control), 0.25%, 0.5%, 1%, 2% and 4% postbiotics. These experimental diets were fed to three replicates of 70 juvenile prawns (initial weight 0.110 ± 0.010 g) for eight weeks. In addition, a diet containing 0.2% florfenicol (FFC0.2) was included as the antibiotic treatment, which was fed to the prawns for two weeks. Results showed that feeding the prawns on the postbiotics diets improved weight gain and survival rate. The prawns fed on the antibiotics or postbiotics diets increased antioxidant capacity in the hepatopancreas. Moreover, the prawns fed on the postbiotics diets increased significantly non-specific immunity. The optimum amount of postbiotics required for maximum non-specific immunity was 0.76%, 0.86% and 2.85% based on acid phosphatase, alkaline phosphatase and phenoloxidase activities, respectively. The prawns fed on the postbiotics diets upregulated significantly the mRNA expression of immunity related genes, which were downregulated significantly in the prawns fed on the FFC0.2 diet. Furthemore, the prawns fed on the 1% and 2% postbiotics diets had longer microvilli with closely packed intestinal epithelial cell and basement membrane. In summary, supplementing 0.76 to 2.66% postbiotics in the diets for M. nipponense improves growth performance, survival rate, antioxidant capacity, non-specific immunity and gut health compared with florfenicol antibiotic.